High flow nasal cannula for acute respiratory failure due to COVID‐19 in patients with a ‘do‐not‐intubate’ order: A survival analysis

INTRODUCTION: High flow nasal cannula (HFNC) reduces the need for intubation in patients with hypoxaemic acute respiratory failure (ARF), but its added value in patients with severe coronavirus disease 2019 (COVID‐19) and a do‐not‐intubate (DNI) order is unknown. We aimed to assess (variables associ...

Descripción completa

Detalles Bibliográficos
Autores principales: Smesseim, Illaa, Mooij‐Kalverda, Kirsten, Hessels, Lisa, Korevaar, Daniel A., Atasever, Burak, de Graaff, Hjalmar, Goorhuis, Abraham, Nossent, Esther, Bos, Lieuwe, Bonta, Peter, van den Aardweg, Joost, Boersma, Wim, van der Lee, Ivo, Reesink, Herre J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Brief Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9880618/
https://www.ncbi.nlm.nih.gov/pubmed/36584670
http://dx.doi.org/10.1111/crj.13573

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9880618/
https://www.ncbi.nlm.nih.gov/pubmed/36584670
http://dx.doi.org/10.1111/crj.13573

Ejemplares similares